Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies
This study has been terminated.
Sponsor:
Titan Pharmaceuticals
Information provided by:
Titan Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00050687
First received: December 17, 2002
Last updated: January 21, 2011
Last verified: November 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | March 2005 |
| Primary Completion Date: | March 2005 (Final data collection date for primary outcome measure) |